Fecal metabolic dysbiosis predicts 30-day mortality in critically ill patients and is a potentially treatable trait to improve survival.
A fecal metabolic dysbiosis score predicted 30-day mortality in critically ill patients and may help identify fecal metabolites as a potential treatable trait to improve survival in these patients.Researchers prospectively collected fecal specimens from 196 critically ill patients admitted to the medical intensive care unit for non-COVID-19 respiratory failure or shock.
They analyzed the specimens, defined microbiome compositions by shotgun metagenomic sequencing, and quantified microbiota-derived fecal metabolites by mass spectrometry.Overall, 30-day mortality was 30.6%. There was no significant difference between survivors and nonsurvivors regarding age, sex, race, and comorbidity burden. Microbiota compositions of the first fecal sample after MICU admission did not independently associate with 30-day mortality, nor were there associations between single metabolites and 30-day mortality. However, by integrating the fecal metabolite concentrations of 13 microbiota-derived metabolites, the team developed an MDS that predicted 30-day mortality independent of known confounders. The MDS may complement existing tools to identify patients at high risk for mortality by incorporating potentially modifiable, microbiome-related, independent contributors to host resilience.“Fecal metabolic dysbiosis, determined by quantitation of 13 fecal metabolites, is independently associated with 30-day mortality after MICU admission in our cohort,” the study authors wrote. “Therefore, fecal metabolic dysbiosis represents a potentially treatable trait to improve survival in heterogeneous critically ill patients,” and the MDS may serve as a biomarker to identify patients who might benefit from such treatment.The study had limitations. Patients were recruited at a single tertiary academic center and needed respiratory support or a vasopressor, and thus, the results might not be representative of the entire medical ICU population. Also, patients who did not produce a fecal sample or gave a sample that was not analyzable for metagenomics and metabolomics were excluded.The study was funded by the Duchossois Family Institute. de Porto was funded by the Niels Stensen Fellowship. The Center for Research Informatics is funded by the Biological Sciences Division at the University of Chicago, with additional funding provided by the Institute for Translational Medicine and the National Institutes of Health . One co-author was funded by the NIH/National Heart, Lung, and Blood Institute.Trump Nominations for US Health Agencies Spark Controversy, Criticism, PraiseAll material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.
Microbiota Metabolism Metabolic Medical Intensive Care Unit Medical ICU Medical Intensive Care Unit (MICU) Biomarker Biological Marker Multi-Biomarker Disease Activity MBDA Multibiomarker Disease Activity Blood Fellowship Fellows Heart Intensive Care Unit Intensive Care Unit (ICU) Lung Mass Spectrometry Respiratory Failure Shock
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Over 100 Studies Show This Nutrient Is A Key Player For Metabolic HealthHint: Gym bros can't get enough of it.
Read more »
The metabolic health crisis sweeping America — and the Utah solution that's changing livesThere's no denying that many people in Utah along with most Americans are getting sicker and fatter. Fortunately, a health shake with Utah connections is helping solve the problem.
Read more »
The metabolic health crisis sweeping America — and the Utah solution that's changing livesThere's no denying that many people in Utah along with most Americans are getting sicker and fatter. Fortunately, a health shake with Utah connections is helping solve the problem.
Read more »
A high-fat diet sets off metabolic dysfunction in cells, leading to weight gainResearchers find high-fat diets set off metabolic dysfunction in cells, leading to weight gain, but these effects can be reversed by treatment with an antioxidant.
Read more »
Novel Gene Risk Score Predicts Outcomes After RYGB SurgeryA new gene risk score, informed by machine learning, can predict weight-loss outcomes after Roux-en-Y gastric bypass surgery.
Read more »
HairCortisone Predicts Metabolic Syndrome in Young AdultsA cross-sectional study shows that hair glucocorticoids, a marker of chronic stress, are strongly associated with metabolic syndrome and its components, particularly in younger adults.
Read more »